5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.35%
Revenue growth above 1.5x UPM.HE's 2.10%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
12.82%
Positive gross profit growth while UPM.HE is negative. John Neff would see a clear operational edge over the competitor.
27.13%
EBIT growth above 1.5x UPM.HE's 10.28%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
27.13%
Operating income growth above 1.5x UPM.HE's 10.28%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
27.59%
Net income growth 1.25-1.5x UPM.HE's 19.79%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
121.43%
EPS growth above 1.5x UPM.HE's 20.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
121.43%
Diluted EPS growth above 1.5x UPM.HE's 20.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.96%
Share change of 0.96% while UPM.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.96%
Diluted share change of 0.96% while UPM.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-79.26%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-142.71%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-29.04%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
8.85%
Positive 5Y CAGR while UPM.HE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
1.36%
Positive 3Y CAGR while UPM.HE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-52.74%
Negative 10Y OCF/share CAGR while UPM.HE stands at 27.45%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
172.35%
Positive OCF/share growth while UPM.HE is negative. John Neff might see a comparative advantage in operational cash viability.
-43.77%
Negative 3Y OCF/share CAGR while UPM.HE stands at 4.33%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
121.16%
Net income/share CAGR above 1.5x UPM.HE's 29.23% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
152.75%
Positive 5Y CAGR while UPM.HE is negative. John Neff might view this as a strong mid-term relative advantage.
17.95%
Positive short-term CAGR while UPM.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
40.04%
10Y equity/share CAGR above 1.5x UPM.HE's 23.05%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
41.47%
5Y equity/share CAGR above 1.5x UPM.HE's 14.20%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
28.79%
3Y equity/share CAGR above 1.5x UPM.HE's 1.42%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.14%
AR growth is negative/stable vs. UPM.HE's 87150.00%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
10.18%
Inventory growth well above UPM.HE's 4.57%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
13.64%
Asset growth above 1.5x UPM.HE's 7.31%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
12.97%
Positive BV/share change while UPM.HE is negative. John Neff sees a clear edge over a competitor losing equity.
2.86%
Debt shrinking faster vs. UPM.HE's 29.34%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-49.54%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.